AGGF1 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 6.898500E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
2.241800E-01
Normal-vs-Stage2
5.542500E-02
Normal-vs-Stage3
2.096300E-03
Normal-vs-Stage4
4.251200E-01
Stage1-vs-Stage2
2.151800E-01
Stage1-vs-Stage3
1.079550E-02
Stage1-vs-Stage4
9.150600E-01
Stage2-vs-Stage3
8.071700E-02
Stage2-vs-Stage4
3.842600E-01
Stage3-vs-Stage4
1.026960E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
5.920000E-02
Normal-vs-AfricanAmerican
3.025600E-01
Normal-vs-Asian
8.798400E-02
Caucasian-vs-AfricanAmerican
2.680800E-01
Caucasian-vs-Asian
3.855800E-01
AfricanAmerican-vs-Asian
2.246800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
5.188200E-02
Normal-vs-Female
1.053820E-01
Male-vs-Female
2.358200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
1.160180E-01
Normal-vs-Age(41-60Yrs)
1.687980E-01
Normal-vs-Age(61-80Yrs)
5.000100E-02
Normal-vs-Age(81-100Yrs)
1.424180E-02
Age(21-40Yrs)-vs-Age(41-60Yrs)
9.353400E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
4.982400E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
3.628200E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
3.578400E-02
Age(41-60Yrs)-vs-Age(81-100Yrs)
2.406600E-01
Age(61-80Yrs)-vs-Age(81-100Yrs)
9.818800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
8.159200E-03
Normal-vs-Daily Drinker
1.933820E-02
Normal-vs-Weekly Drinker
8.823800E-02
Normal-vs-Occasional Drinker
1.356360E-01
Normal-vs-Social Drinker
2.881200E-01
Non Drinker-vs-Daily Drinker
5.882800E-01
Non Drinker-vs-Weekly Drinker
5.734200E-01
Non Drinker-vs-Occasional Drinker
6.775900E-02
Non Drinker-vs-Social Drinker
1.273520E-02
Daily Drinker-vs-Weekly Drinker
8.960600E-01
Daily Drinker-vs-Occasional Drinker
2.069400E-01
Daily Drinker-vs-Social Drinker
5.369600E-02
Weekly Drinker-vs-Occasional Drinker
3.858200E-01
Weekly Drinker-vs-Social Drinker
1.622790E-01
Occasional Drinker-vs-Social Drinker
4.881600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
1.140370E-01
Normal-vs-Grade 2
4.148200E-02
Normal-vs-Grade 3
3.271600E-02
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
8.391800E-01
Grade 1-vs-Grade 3
8.888400E-01
Grade 1-vs-Grade 4
1.140370E-01
Grade 2-vs-Grade 3
6.456000E-01
Grade 2-vs-Grade 4
4.148200E-02
Grade 3-vs-Grade 4
3.271600E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
3.171800E-02
Normal-vs-NonDiabetic
5.619600E-02
Diabetic-vs-NonDiabetic
3.292800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
9.997900E-03
Normal-vs-NoPancreatitis
6.788300E-02
Pancreatitis-vs-NoPancreatitis
2.190000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
1.130210E-01
Normal-vs-N1
5.987500E-02
N0-vs-N1
9.100600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
1.275610E-01
Normal-vs-TP53-NonMutant
4.002800E-01
TP53-Mutant-vs-TP53-NonMutant
8.245900E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
